These agents often target specific aspects of cell division or DNA replication; (4) Hormone therapies—these target hormone-dependent cancers by interfering with the action of specific hormones or hormone receptors; (5) Antimicrotubule agents—these drugs target the microtubules, which play an essential role in cell division. Here, NR4A1 is linked to cancer.